205 related articles for article (PubMed ID: 19123976)
1. Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity.
Kim HN; Chung HS
BMB Rep; 2008 Dec; 41(12):858-62. PubMed ID: 19123976
[TBL] [Abstract][Full Text] [Related]
2. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
3. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
4. Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking.
Wu YI; Munshi HG; Snipas SJ; Salvesen GS; Fridman R; Stack MS
Biochem J; 2007 Oct; 407(2):171-7. PubMed ID: 17650075
[TBL] [Abstract][Full Text] [Related]
5. MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion.
Woskowicz AM; Weaver SA; Shitomi Y; Ito N; Itoh Y
J Biol Chem; 2013 Dec; 288(49):35126-37. PubMed ID: 24165131
[TBL] [Abstract][Full Text] [Related]
6. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
Roy S; Chakraborti T; Chowdhury A; Chakraborti S
J Biochem; 2013 Mar; 153(3):289-302. PubMed ID: 23266860
[TBL] [Abstract][Full Text] [Related]
7. Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells.
Rozanov DV; Deryugina EI; Monosov EZ; Marchenko ND; Strongin AY
Exp Cell Res; 2004 Feb; 293(1):81-95. PubMed ID: 14729059
[TBL] [Abstract][Full Text] [Related]
8. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
9. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase.
Labrecque L; Nyalendo C; Langlois S; Durocher Y; Roghi C; Murphy G; Gingras D; Béliveau R
J Biol Chem; 2004 Dec; 279(50):52132-40. PubMed ID: 15466865
[TBL] [Abstract][Full Text] [Related]
10. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains.
Annabi B; Lachambre M; Bousquet-Gagnon N; Pagé M; Gingras D; Béliveau R
Biochem J; 2001 Feb; 353(Pt 3):547-53. PubMed ID: 11171051
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
[TBL] [Abstract][Full Text] [Related]
12. The tetraspanin network modulates MT1-MMP cell surface trafficking.
Schröder HM; Hoffmann SC; Hecker M; Korff T; Ludwig T
Int J Biochem Cell Biol; 2013 Jun; 45(6):1133-44. PubMed ID: 23500527
[TBL] [Abstract][Full Text] [Related]
13. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
14. The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Leong HS; Damjanovski S
Exp Cell Res; 2017 Jan; 350(1):169-183. PubMed ID: 27889376
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
[TBL] [Abstract][Full Text] [Related]
17. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis.
Jiang A; Lehti K; Wang X; Weiss SJ; Keski-Oja J; Pei D
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13693-8. PubMed ID: 11698655
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a cooperative role of gelatinase A and membrane type-1 matrix metalloproteinase during Xenopus laevis development.
Hasebe T; Hartman R; Fu L; Amano T; Shi YB
Mech Dev; 2007 Jan; 124(1):11-22. PubMed ID: 17055228
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
